# Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).

> **NCT01746706** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 80 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DEVICE:** PET amyloid tracer (Florbetapir F18 AV45 F18

## Key facts

- **NCT ID:** NCT01746706
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2015-11
- **Final completion:** 2017-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746706, "Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01746706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*